Maas AIR, Menon DK, Manley GT et al (2022) Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol 21:1004–1060. https://doi.org/10.1016/S1474-4422(22)00309-X

Article  PubMed  PubMed Central  Google Scholar 

Chong SL, Dang H, Ming M et al (2021) Traumatic brain injury outcomes in 10 Asian pediatric ICUs: a pediatric acute and critical care medicine asian network retrospective study. Pediatr Crit Care Med 22:401–411. https://doi.org/10.1097/PCC.0000000000002575

Article  PubMed  Google Scholar 

Di Battista AP, Rhind SG, Hutchison MG et al (2016) Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation 13:40

Article  PubMed  PubMed Central  Google Scholar 

Hinson HE, Rowell S, Schreiber M (2015) Clinical evidence of inflammation driving secondary brain injury: a systematic review. J Trauma Acute Care Surg 78:184–191. https://doi.org/10.1186/s12974-016-0500-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stocchetti N, Maas AI (2014) Traumatic intracranial hypertension. N Engl J Med 370:2121–2130. https://doi.org/10.1056/NEJMra1208708

Article  CAS  PubMed  Google Scholar 

Ferreira LC, Regner A, Miotto KD et al (2014) Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury. Brain Inj 28:1311–1316. https://doi.org/10.3109/02699052.2014.916818

Article  PubMed  Google Scholar 

Johnson NH, Hadad R, Taylor RR et al (2022) Inflammatory biomarkers of traumatic brain injury. Pharmaceuticals (Basel) 15:660. https://doi.org/10.3390/ph15060660

Article  CAS  PubMed  Google Scholar 

Venetsanou K, Vlachos K, Moles A et al (2007) Hypolipoproteinemia and hyperinflammatory cytokines in serum of severe and moderate traumatic brain injury (TBI) patients. Eur Cytokine Netw 18:206–209. https://doi.org/10.1684/ecn.2007.0112

Article  CAS  PubMed  Google Scholar 

Beers SR, Wisniewski SR, Garcia-Filion P et al (2012) Validity of a pediatric version of the Glasgow Outcome Scale-Extended. J Neurotrauma 29:1126–1139. https://doi.org/10.1089/neu.2011.2272

Article  PubMed  PubMed Central  Google Scholar 

McCauley SR, Wilde EA, Anderson VA et al (2012) Recommendations for the use of common outcome measures in pediatric traumatic brain injury research. J Neurotrauma 29:678–705. https://doi.org/10.1089/neu.2011.1838

Article  PubMed  PubMed Central  Google Scholar 

Ludwig NN, Suskauer SJ, Rodgin S et al (2023) Outcome measurement in children with a history of disorders of consciousness after severe brain injury: telephone administration of the Vineland Adaptive Behavior Scales, third edition, and Glasgow Outcome Scale-Extended Pediatric Revision. Pediatr Crit Care Med 24:e76–e83. https://doi.org/10.1097/PCC.0000000000003121

Article  PubMed  Google Scholar 

Cannon AR, Anderson LJ, Galicia K et al (2023) Traumatic brain injury-induced inflammation and gastrointestinal mortility dysfunction. Shock 59:621–626. https://doi.org/10.1097/SHK.0000000000002082

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsitsipanis C, Miliaraki M, Paflioti E et al (2023) Inflammation biomarkers IL-6 and IL-10 may improve the diagnostic and prognostic accuracy of currently authorized traumatic brain injury tools. Exp Ther Med 26:364. https://doi.org/10.3892/etm.2023.12063

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edwards KA, Gill JM, Pattinson CL et al (2020) Interleukin-6 is associated with acute concussion in military combat personnel. BMC Neurol 20:209. https://doi.org/10.1186/s12883-020-01760-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yousefzadeh-Chabok S, Dehnadi Moghaddam A et al (2015) The relationship between serum levels of interleukins 6, 8, 10 and clinical outcome in patients with severe traumatic brain injury. Arch Trauma Res 4:e18357. https://doi.org/10.5812/atr.18357

Article  PubMed  PubMed Central  Google Scholar 

Ryan E, Kelly L, Stacey C et al (2022) Mild-to-severe traumatic brain injury in children: altered cytokines reflect severity. J Neuroinflammation 19:36. https://doi.org/10.1186/s12974-022-02390-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lo TY, Jones PA, Minns RA (2010) Combining coma score and serum biomarker levels to predict unfavorable outcome following childhood brain trauma. J Neurotrauma 27:2139–2145. https://doi.org/10.1089/neu.2010.1387

Article  PubMed  Google Scholar 

Park SH, Hwang SK (2018) Prognostic value of serum levels of S100 calcium-binding protein b, neuron-specific enolase, and interleukin-6 in pediatric patients with traumatic brain injury. World Neurosurg 118:e534–e542. https://doi.org/10.1016/j.wneu.2018.06.234

Article  PubMed  Google Scholar 

Chiaretti A, Antonelli A, Mastrangelo A et al (2008) Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J Neurotrauma 25:225–234. https://doi.org/10.1089/neu.2007.0405

Article  PubMed  Google Scholar 

Rowland B, Savarraj JPJ, Karri J et al (2020) Acute inflammation in traumatic brain injury and polytrauma patients using network analysis. Shock 53:24–34. https://doi.org/10.1097/SHK.0000000000001349

Article  PubMed  PubMed Central  Google Scholar 

Yan EB, Satgunaseelan L, Paul E et al (2014) Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury. J Neurotrauma 31:618–629. https://doi.org/10.1089/neu.2013.3087

Article  PubMed  PubMed Central  Google Scholar 

Chaban V, Clarke GJB, Skandsen T et al (2020) Systemic inflammation persists the first year after mild traumatic brain injury: results from the prospective trondheim mild traumatic brain injury study. J Neurotrauma 37:2120–2130. https://doi.org/10.1089/neu.2019.6963

Article  PubMed  PubMed Central  Google Scholar 

Crichton A, Ignjatovic V, Babl FE et al (2021) Interleukin-8 predicts fatigue at 12 months post-injury in children with traumatic brain injury. J Neurotrauma 38:1151–1163. https://doi.org/10.1089/neu.2018.6083

Article  PubMed  Google Scholar 

Gopcevic A, Mazul-Sunko B, Marout J et al (2007) Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. Tohoku J Exp Med 211:387–393. https://doi.org/10.1620/tjem.211.387

Article  CAS  PubMed  Google Scholar 

Lee S, Hwang H, Yamal JM et al (2019) IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury. J Neurosurg 131:1931–1937

Article  CAS  PubMed  Google Scholar 

Aisiku IP, Yamal JM, Doshi P et al (2016) Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury. Crit Care 20:288. https://doi.org/10.1186/s13054-016-1470-7

Article  PubMed  PubMed Central  Google Scholar 

Iyer SS, Cheng G (2020) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32:23–63. https://doi.org/10.1615/critrevimmunol.v32.i1.30

Article  Google Scholar 

Schneider Soares FM, Menezes de Souza N, Libório Schwarzbold M et al (2012) Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis. NeuroImmunoModulation 19:377–385. https://doi.org/10.1159/000342141

Article  CAS  PubMed  Google Scholar 

Lagerstedt L, Azurmendi L, Tenovuo O et al (2020) Interleukin 10 and heart fatty acid-binding protein as early outcome predictors in patients with traumatic brain injury. Front Neurol 11:376. https://doi.org/10.3389/fneur.2020.00376

Article  PubMed  PubMed Central  Google Scholar 

Kumar RG, DiSanto D, Awan N et al (2020) Temporal acute serum estradiol and tumor necrosis factor-α associations and risk of death after severe traumatic brain injury. J Neurotrauma 37:2198–2210. https://doi.org/10.1089/neu.2019.6577

Article  PubMed  PubMed Central  Google Scholar